These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38374283)
21. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114 [TBL] [Abstract][Full Text] [Related]
22. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease. Hu Y; Chen Z; Xu C; Kan S; Chen D Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169 [TBL] [Abstract][Full Text] [Related]
23. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art. Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766 [TBL] [Abstract][Full Text] [Related]
24. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644 [TBL] [Abstract][Full Text] [Related]
25. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease. Yadav A; Yadav R; Sharma V; Dutta U Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485 [TBL] [Abstract][Full Text] [Related]
26. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. Yu LC J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188 [TBL] [Abstract][Full Text] [Related]
28. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients. Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669 [TBL] [Abstract][Full Text] [Related]
29. Dynamics of the human gut microbiome in inflammatory bowel disease. Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease: between genetics and microbiota. Younis N; Zarif R; Mahfouz R Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718 [TBL] [Abstract][Full Text] [Related]
31. Metabarcoding of colonic cleansing fluid reveals unique bacterial members of mucosal microbiota associated with Inflammatory Bowel Disease. Banzragch M; Sanli K; Stensvold CR; Kurt O; Ari S Scand J Gastroenterol; 2023; 58(11):1253-1263. PubMed ID: 37337895 [TBL] [Abstract][Full Text] [Related]
32. Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases. Lawal SA; Voisin A; Olof H; Bording-Jorgensen M; Armstrong H Front Immunol; 2023; 14():1242242. PubMed ID: 38022505 [TBL] [Abstract][Full Text] [Related]
33. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Qv L; Mao S; Li Y; Zhang J; Li L Front Cell Infect Microbiol; 2021; 11():755650. PubMed ID: 34900751 [TBL] [Abstract][Full Text] [Related]
34. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. Said HS; Suda W; Nakagome S; Chinen H; Oshima K; Kim S; Kimura R; Iraha A; Ishida H; Fujita J; Mano S; Morita H; Dohi T; Oota H; Hattori M DNA Res; 2014 Feb; 21(1):15-25. PubMed ID: 24013298 [TBL] [Abstract][Full Text] [Related]
35. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Sartor RB; Wu GD Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810 [TBL] [Abstract][Full Text] [Related]
36. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis. Henson MA; Phalak P BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051 [TBL] [Abstract][Full Text] [Related]
37. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401 [TBL] [Abstract][Full Text] [Related]
38. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease. Park YM; Ha E; Gu KN; Shin GY; Lee CK; Kim K; Kim HJ Clin Transl Gastroenterol; 2020 Jul; 11(7):e00213. PubMed ID: 32764209 [TBL] [Abstract][Full Text] [Related]
39. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876 [TBL] [Abstract][Full Text] [Related]
40. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages. Bauset C; Carda-Diéguez M; Cejudo-Garcés A; Buetas E; Seco-Cervera M; Macias-Ceja DC; Navarro-Vicente F; Esplugues JV; Calatayud S; Mira Á; Ortiz-Masiá D; Barrachina MD; Cosín-Roger J Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167489. PubMed ID: 39233260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]